Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelosuppression”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableStudy completedNCT03590938
What this trial is testing

Lynparza Breast Cancer Clinical Experience Investigation

Who this might be right for
Breast Cancer
AstraZeneca 111
Not applicableUnknownNCT01193933
What this trial is testing

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

Who this might be right for
Ph-negative Adult Acute Lymphoblastic Leukemia
National Research Center for Hematology, Russia 321
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Not applicableUnknownNCT02829216
What this trial is testing

Graft-versus-host Disease Associated Myelosuppression

Who this might be right for
Abnormal HematopoiesisAllogenic DiseaseGraft vs Host Disease
Technische Universität Dresden 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT06665737
What this trial is testing

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Granulocyte Colony Stimulating FactorFebrile Neutropenia (FN)+1 more
Department of Medical Services Ministry of Public Health of Thailand 126
Testing effectiveness (Phase 2)UnknownNCT00243165
What this trial is testing

Lifemel Honey to Reduce Leucopenia During Chemotherapy

Who this might be right for
Breast Cancer
Rambam Health Care Campus 60
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 733
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Looking for participantsNCT06698965
What this trial is testing

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

Who this might be right for
Lung Cancer, Small Cell
Shanghai Chest Hospital 52
Testing effectiveness (Phase 2)Study completedNCT02692742
What this trial is testing

Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia

Who this might be right for
Chemotherapy-Induced NeutropeniaMyelosuppressionBreast Cancer
Myelo Therapeutics GmbH 137
Post-approval studies (Phase 4)Looking for participantsNCT05874401
What this trial is testing

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Pharmacosmos A/S 302
Not applicableStudy completedNCT01060410
What this trial is testing

Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

Who this might be right for
Lupus Erythematosus, SystemicAdverse Effects
Sun Yat-sen University 222
Not applicableStudy completedNCT03719118
What this trial is testing

Tailored Therapeutic Model According to the Expression of Genes in Inflammatory Bowel Disease Patients

Who this might be right for
Inflammatory Bowel Diseases
Yonsei University 215
Not applicableStudy completedNCT03247010
What this trial is testing

Bone Marrow Suppression and Recovery During Radionuclide Treatment

Who this might be right for
Castration-resistant Prostate Cancer
Rigshospitalet, Denmark 68
Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Not applicableUnknownNCT06140082
What this trial is testing

Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression

Who this might be right for
Non-small Cell Lung Cancer
LI YAN 477
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07096583
What this trial is testing

An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

Who this might be right for
Ovary Cancer
Anhui Provincial Cancer Hospital 20
Load More Results